Nasacort AQ

151,00 EGP

55 mcg/dose nasal spray 120 doses

Compare

Description

Trade name:
Nasacort AQ

Composition:
Each dose of the drug contains:

Triamcinolone acetonide 55 mcg.
Properties:
The drug belongs to the group of intranasal glucocorticosteroids.

It has anti-inflammatory, anti-allergic, anti-edematous effects. Reduces bronchial hyperreactivity.

In therapeutic doses, it has virtually no systemic effects, does not suppress the function of the adrenal cortex; does not cause sodium retention in the body and the appearance of edema.

Onset of action – after 12 hours, reaches a maximum on the 4-7th day of therapy.

Indications:
Seasonal and year-round allergic rhinitis (prevention and treatment), accompanied by symptoms such as congestion, itching, sneezing and nasal discharge. The drug is effective only with course use and is not indicated for immediate relief of symptoms.
Method of administration and dosage:
Intranasally, for adults and children over 12 years old: 220 mcg/day (2 inhalation doses in each nasal passage), once; if necessary, the dosage can be increased to a maximum of 440 mcg/day (used once or divided into 2-4 doses).

Children aged 6-12 years: 110 mcg/day (1 inhalation dose in each nasal passage), once. The maximum daily dose is 220 mcg.

After achieving the therapeutic effect, in some patients it is possible to reduce the daily dose to the minimum maintenance dose of 110 mcg/day; the dose is reduced gradually, decreasing it by 55 mcg/day (1 inhalation dose), every 4-7 days.

Contraindications:
Hypersensitivity, childhood (under 6 years), pregnancy, lactation.

With caution: Tuberculosis, acute fungal, bacterial and viral infections, herpetic eye lesions.
Precautions:
Intranasal use in patients with nasal septum ulcers, nasal injuries or after surgical operations in the nasal area may slow down wound healing.

In case of development of candidiasis of the mucous membranes of the nose or pharynx, the drug should be discontinued and appropriate therapy should be prescribed.

Do not use for more than 3 months in children under 12 years of age to avoid systemic effects.

Side effects:
Headache, sneezing, cough, dry mucous membrane of the nasal cavity, irritation in the nose, nosebleeds, pharyngitis, rhinitis, fungal infection of the nose and pharynx caused by Candida albicans. In children aged 6-12 years – sinusitis, otitis media, vomiting.
Storage:
Store in a dry, cool place at a temperature not exceeding 30 degrees.
Packaging:
The cardboard box contains a dosing device for 120 doses, paper instructions.